Leukemia, lymphoma, myeloma and myelodysplastic syndromes (MDS) are types of cancer that can affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
Click on the links below to view statistics about each disease:
- Approximately every 3 minutes one person in the United States (US) is diagnosed with a blood cancer.
- An estimated combined total of 162,020 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2015.
- New cases of leukemia, lymphoma and myeloma are expected to account for 9.8 percent of the estimated 1,658,370 new cancer cases diagnosed in the US in 2015.
- Prevalence is the estimated number of people alive on a certain date in a population who previously had a diagnosis of the disease. An estimated 1,185,053 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.
- Relative survival compares the survival rate of a person diagnosed with a disease to that of a person without the disease. The most recent survival data available may not fully represent the outcomes of all current therapies and, as a result, may underestimate survival to a small degree.
- Approximately every 9 minutes, someone in the US dies from a blood cancer. This statistic represents nearly 155 people each day or more than six people every hour.
- Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 56,630 people in the US in 2015.
- These diseases are expected to account for 9.6 percent of the deaths from cancer in 2015, based on the estimated total of 589,430 cancer deaths.
- In 2015, 54,270 people are expected to be diagnosed with leukemia.
- There are an estimated 327,520 people living with, or in remission from, leukemia in the US.
- The overall five-year relative survival rate for leukemia has more than quadrupled since 1960. From 1960 to 1963, the five-year relative survival rate among whites (only data available) with leukemia was 14 percent. From 1975 to 1977, the five-year relative survival rate for the total population with leukemia was 34.2 percent, and from 2004 to 2010, the overall relative survival rate was 60.3 percent.
- From 2004-2010, the five-year relative survival rates overall were
- CML - 59.9 percent
- CLL - 83.5 percent
- AML - 25.4 percent overall and 66.3 percent for children and adolescents younger than 15 years
- ALL - 70 percent overall, 91.8 percent for children and adolescents younger than 15 years, and 93 percent for children younger than 5 years.
- In 2015, 24,450 people are expected to die from leukemia (14,040 males and 10,050 females).
- In 2007-2011, leukemia was the fifth most common cause of cancer deaths in men and the sixth most common in women in the US.
- In 2015, there are expected to be 80,900 new cases of lymphoma diagnosed in the US (9,050 cases of HL, 71,850 cases of NHL).
- There are an estimated 761,659 people living with, or in remission from, lymphoma in the US.
- There are 177,526 people living with Hodgkin lymphoma
- There are 584,133 people living with non-Hodgkin lymphoma
- The five-year relative survival rate for people with HL has more than doubled, from 40 percent in whites from 1960-1963 (only data available) to 87.7 percent for all races in 2004-2010. The five-year relative survival rate is 93.7 percent for people with HL who were less than 45 years old at diagnosis.
- HL is now considered to be one of the most curable forms of cancer.
- The five-year relative survival rate for people with NHL has risen from 31 percent in whites from 1960-1963 (only data available) to 71.4 percent for all races in 2004-2010.
- In 2015, 20,940 people are expected to die from lymphoma (1,150 from HL, 19,790 from NHL).
- An estimated 26,850 new cases of myeloma (14,090 males and 12,760 females) are expected to be diagnosed in the US in 2015.
- An estimated 95,874 people in the US are living with, or in remission from, myeloma.
- Five-year relative survival has increased from 12 percent in 1960-1963 among whites (only data available) to 46.7 percent from 2004-2010 among all races and ethnicities.
- The three-year survival rate as of January 1, 2011, is 60 percent (for all races and ethnicities).
- Approximately 11,240 deaths from myeloma are anticipated in 2015.
- For the five-year period from 2007 to 2011 there were approximately 73,888 new cases of MDS throughout the US, averaging an estimated 14,778 cases per year.
- There were approximately 41,291 cases in males (averaging 8,258 per year) and 32,597 cases in females (averaging 6,519 per year).
- The SEER program only recently began maintaining statistics for MDS. Prevalence and mortality statistics were not reported by SEER for MDS in 2015 at the time of this publication.
- Mortality rates were not reported by SEER for MDS in 2015 at the time of this publication.
- Facts 2014-2015. The incidence, prevalence and mortality data in Facts 2014-2015 reflect the statistics from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program, Cancer Statistics Review (CSR) 1975-2011.
- Cancer Facts & Figures 2015. Atlanta, GA: American Cancer Society; 2015.